胸腔血管覆膜支架市場:現況分析與預測（2023-2030）

Thoracic Vascular Stent Graft Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年02月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 156 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

胸部血管支架移植物是一種特殊類型的血管內支架移植物，旨在支撐和加強胸部薄弱或受損的動脈壁。使用微創技術將支架移植物插入受影響的血管，通常是經由腹股溝的動脈，並引導至主動脈的目標部位。一旦支架移植物就位，它就會擴張以創建新的血流路徑，從而將血液從受影響的區域轉移出去，並降低破裂和其他併發症的風險。由於多種因素，胸部血管覆膜支架市場正在快速成長。首先，主動脈疾病的盛行率不斷上升，特別是在人口老化中，刺激了對有效治療方案的需求。此外，微創技術的進步使這些手術對患者來說更容易、更安全，進一步推動市場成長。例如，根據美國疾病管制與預防中心的數據，大約 2% 的美國人患有瓣膜性心臟病。

2022 年，胸腔血管覆膜支架市值為 2.5 億美元，預估 2023 年至 2030 年複合年增長率約為 6%。

依產品劃分，市場分為塑膠胸腔血管支架移植物及金屬胸腔血管支架移植物。近年來，金屬胸腔覆膜支架的需求不斷增加。這些專用醫療器材廣泛用於治療胸主動脈瘤和其他涉及胸主動脈的疾病。金屬胸腔覆膜支架的需求增加是由於多種因素造成的。首先，醫療和外科技術的進步提高了這些設備的安全性和有效性，使它們成為許多醫療保健專業人員的首選。

依最終用戶劃分，市場分為醫院、門診手術中心等。其中，醫院類別將在2022年佔據較大市場。這主要是由於醫院進行了大量的治療，並且在這種環境下擁有先進的醫療設備和專業知識。

為了更了解該產業的市場實施情況，我們根據其在北美、歐洲、亞太地區和世界其他地區的全球分佈對市場進行了分析。到2022年，北美將在胸血管覆膜支架市場佔據壓倒性。北美完善的醫療基礎設施、不斷上漲的醫療成本和不斷增加的血管疾病病例是推動北美市場成長的主要因素。

市場上營運的主要公司包括 Medtronic、Artivion, Inc、Cook Medical、MicroPort Scientific Corporation、Terumo Corporation、Gore Medical、Lamed、Cordis、Vascumed (Pty) Ltd、LeMaitre Vascular, Inc.。

A thoracic vascular stent graft is a specialized type of endovascular stent graft that is designed to provide support and reinforce the weakened or damaged arterial walls in the thoracic region. It is inserted into the affected blood vessel using minimally invasive techniques, typically through an artery in the groin, and then guided to the target site in the aorta. Once in position, the stent graft expands and forms a new pathway for blood flow, thereby diverting it away from the diseased area and reducing the risk of rupture or other complications. The market for thoracic vascular stent grafts has been rapidly growing due to several factors. Firstly, the increasing prevalence of aortic diseases, particularly in the aging population, has fueled the demand for effective treatment options. Additionally, advancements in minimally invasive techniques have made these procedures more accessible and safer for patients, further driving market growth. For Instance, as per the data of the Centre of Disease Control and Prevention, about 2% of the US Population has valvular disease.

The Thoracic Vascular Stent Graft Market was valued at USD 250 Million in 2022 and is expected to grow at a CAGR of around 6% from 2023-2030.

Based on the product, the market is segmented into plastic thoracic vascular stent grafts and metal thoracic vascular stent grafts. Metal thoracic stent grafts have been experiencing an increasing demand in recent years. These specialized medical devices are widely used in the treatment of thoracic aortic aneurysms and other disorders involving the thoracic aorta. The growing demand for metal thoracic stent grafts can be attributed to several factors. Firstly, advancements in medical technologies and surgical techniques have improved the safety and efficacy of these devices, making them a preferred choice for many healthcare professionals.

On the basis of end-users, the market is categorized into Hospitals, ambulatory surgical centers, and Others. Among these, the hospital's category held a significant share of the market in 2022. This is mainly due to the high volume of treatments performed in hospitals, as well as the availability of advanced medical equipment and expertise in this setting.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Thoracic Vascular Stent Graft Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure and rising cases of vascular disorders in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include Medtronic, Artivion, Inc, Cook medical, MicroPort Scientific Corporation, Terumo Corporation, Gore Medical, Lamed, Cordis, Vascumed (Pty) Ltd, LeMaitre Vascular, Inc. etc.

1. MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Thoracic Vascular Stent Graft Market
2.2.Research Methodology of the Thoracic Vascular Stent Graft Market
2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. GLOBAL THORACIC VASCULAR STENT GRAFT MARKET

6. MARKET COVID-19 IMPACT

7. GLOBAL THORACIC VASCULAR STENT GRAFT MARKET REVENUE, 2020-2030F

8. MARKET INSIGHTS BY PRODUCT

8.1.Plastic Thoracic Vascular Stent Grafts
8.2.Metal Thoracic Vascular Stent Grafts

9. MARKET INSIGHTS BY END USER

9.1.Hospitals
9.2.Ambulatory Surgical Centres
9.3.Others

10. MARKET INSIGHTS BY REGION

10.1.North America Thoracic Vascular Stent Graft Market
- 10.1.1.U.S.
- 10.1.2.Canada
- 10.1.3.Rest of North America
10.2.Europe Thoracic Vascular Stent Graft Market
- 10.2.1.Germany
- 10.2.2.UK
- 10.2.3.France
- 10.2.4.Italy
- 10.2.5.Spain
- 10.2.6.Rest of Europe
10.3.Asia-Pacific Thoracic Vascular Stent Graft Market
- 10.3.1.China
- 10.3.2.Japan
- 10.3.3.India
- 10.3.4.Rest of APAC
10.4.Rest of the World Thoracic Vascular Stent Graft Market